HK Stock MarketDetailed Quotes

02410 TYK MEDICINES-B

Watchlist
  • 34.200
  • -1.250-3.53%
Market Closed Mar 31 16:08 CST
12.68BMarket Cap-30.35P/E (TTM)

TYK MEDICINES-B Key Stats

All
YOY yoy
Hide blank lines yoy
(FY)Dec 31, 2024
(Q6)Jun 30, 2024
(Q3)Mar 31, 2024
(FY)Dec 31, 2023
(Q9)Sep 30, 2023
(Q3)Mar 31, 2023
(FY)Dec 31, 2022
(Q9)Sep 30, 2022
Turnover
--107K
----
----
----
----
----
--44.24M
--44.24M
Operating income
107K
44.24M
44.24M
Cost of sales
---93K
----
----
----
----
----
---24.2M
---24.2M
Operating expenses
-93K
-24.2M
-24.2M
Gross profit
14K
20.04M
20.04M
Administrative expenses
-82.67%-108.33M
---40.1M
-112.47%-21.66M
-76.83%-59.31M
-41.01%-34.22M
---10.19M
---33.54M
---24.27M
Research and development expenses
5.54%-235.45M
---137.76M
-17.68%-64.7M
-8.46%-249.25M
-28.39%-188.9M
---54.98M
---229.81M
---147.12M
Revaluation surplus
21.89%-60.76M
---47.46M
-25.50%-23.73M
-12.56%-77.79M
-15.24%-57.37M
---18.91M
---69.11M
---49.78M
-Changes in the fair value of other assets
21.89%-60.76M
---47.46M
-25.50%-23.73M
-12.56%-77.79M
-15.24%-57.37M
---18.91M
---69.11M
---49.78M
Special items of operating profit
15.73%29.41M
--11.22M
55.46%4.67M
57.64%25.41M
77.88%20.88M
--3M
--16.12M
--11.74M
Operating profit
-3.93%-375.11M
-214.1M
-30.02%-105.42M
-21.82%-360.94M
-37.07%-259.61M
-81.08M
-296.3M
-189.39M
Financing cost
42.36%-12.82M
---5.43M
-10.48%-2.36M
-43.40%-22.24M
53.47%-6.57M
---2.14M
---15.51M
---14.13M
Earning before tax
-1.24%-387.93M
-219.53M
-29.52%-107.78M
-22.89%-383.17M
-30.79%-266.18M
-83.21M
-311.8M
-203.52M
After-tax profit from continuing operations
-1.24%-387.93M
-219.53M
-29.52%-107.78M
-22.89%-383.17M
-30.79%-266.18M
-83.21M
-311.8M
-203.52M
Earning after tax
-1.24%-387.93M
-219.53M
-29.52%-107.78M
-22.89%-383.17M
-30.79%-266.18M
-83.21M
-311.8M
-203.52M
Minority profit
-30.78%-973K
---480K
-24.15%-257K
8.03%-744K
2.89%-537K
---207K
---809K
---553K
Profit attributable to shareholders
-1.18%-386.96M
-219.05M
-29.53%-107.52M
-22.97%-382.43M
-30.88%-265.65M
-83.01M
-310.99M
-202.97M
Basic earnings per share
12.88%-1.15
-0.68
-17.24%-0.34
-17.86%-1.32
-24.32%-0.92
-0.29
-1.12
-0.74
Diluted earnings per share
12.88%-1.15
-0.68
-17.24%-0.34
-17.86%-1.32
-24.32%-0.92
-0.29
-1.12
-0.74
Currency Unit
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
Accounting Standards
HKAS
HKAS
HKAS
HKAS
HKAS
HKAS
HKAS
HKAS
Audit Opinions
Unqualified Opinion
--
--
Unqualified Opinion
--
--
Unqualified Opinion
--
Auditor
Ernst & Young
--
--
Ernst & Young
--
--
Ernst & Young
--
(FY)Dec 31, 2024(Q6)Jun 30, 2024(Q3)Mar 31, 2024(FY)Dec 31, 2023(Q9)Sep 30, 2023(Q3)Mar 31, 2023(FY)Dec 31, 2022(Q9)Sep 30, 2022
Turnover --107K----------------------44.24M--44.24M
Operating income 107K44.24M44.24M
Cost of sales ---93K-----------------------24.2M---24.2M
Operating expenses -93K-24.2M-24.2M
Gross profit 14K20.04M20.04M
Administrative expenses -82.67%-108.33M---40.1M-112.47%-21.66M-76.83%-59.31M-41.01%-34.22M---10.19M---33.54M---24.27M
Research and development expenses 5.54%-235.45M---137.76M-17.68%-64.7M-8.46%-249.25M-28.39%-188.9M---54.98M---229.81M---147.12M
Revaluation surplus 21.89%-60.76M---47.46M-25.50%-23.73M-12.56%-77.79M-15.24%-57.37M---18.91M---69.11M---49.78M
-Changes in the fair value of other assets 21.89%-60.76M---47.46M-25.50%-23.73M-12.56%-77.79M-15.24%-57.37M---18.91M---69.11M---49.78M
Special items of operating profit 15.73%29.41M--11.22M55.46%4.67M57.64%25.41M77.88%20.88M--3M--16.12M--11.74M
Operating profit -3.93%-375.11M-214.1M-30.02%-105.42M-21.82%-360.94M-37.07%-259.61M-81.08M-296.3M-189.39M
Financing cost 42.36%-12.82M---5.43M-10.48%-2.36M-43.40%-22.24M53.47%-6.57M---2.14M---15.51M---14.13M
Earning before tax -1.24%-387.93M-219.53M-29.52%-107.78M-22.89%-383.17M-30.79%-266.18M-83.21M-311.8M-203.52M
After-tax profit from continuing operations -1.24%-387.93M-219.53M-29.52%-107.78M-22.89%-383.17M-30.79%-266.18M-83.21M-311.8M-203.52M
Earning after tax -1.24%-387.93M-219.53M-29.52%-107.78M-22.89%-383.17M-30.79%-266.18M-83.21M-311.8M-203.52M
Minority profit -30.78%-973K---480K-24.15%-257K8.03%-744K2.89%-537K---207K---809K---553K
Profit attributable to shareholders -1.18%-386.96M-219.05M-29.53%-107.52M-22.97%-382.43M-30.88%-265.65M-83.01M-310.99M-202.97M
Basic earnings per share 12.88%-1.15-0.68-17.24%-0.34-17.86%-1.32-24.32%-0.92-0.29-1.12-0.74
Diluted earnings per share 12.88%-1.15-0.68-17.24%-0.34-17.86%-1.32-24.32%-0.92-0.29-1.12-0.74
Currency Unit CNYCNYCNYCNYCNYCNYCNYCNY
Accounting Standards HKASHKASHKASHKASHKASHKASHKASHKAS
Audit Opinions Unqualified Opinion----Unqualified Opinion----Unqualified Opinion--
Auditor Ernst & Young----Ernst & Young----Ernst & Young--

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Market Insights
HK Dividend Stocks HK Dividend Stocks

Dividend stocks are stocks of companies in the HK stock market that regularly distribute dividends to shareholders, generally representing stable businesses. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in HK dividend stocks, ranked from highest to lowest based on real-time market data. Dividend stocks are stocks of companies in the HK stock market that regularly distribute dividends to shareholders, generally representing stable businesses. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in HK dividend stocks, ranked from highest to lowest based on real-time market data.